A multicenter analysis of abemaciclib after progression on palbociclib in patients (pts) with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Seth Andrew Wander, Mark Zangardi, Andrzej Niemierko, Avinash Kambadakone, Leslie SL Kim, Jing Xi, Apurva Kumari Pandey, Laura Spring, Casey Stein, Dejan Juric, Irene Kuter, Beverly Moy, Therese Marie Mulvey, Neelima Vidula, Steven J. Isakoff, Megan Yuen, Adam Brufsky, Cynthia X. Ma, Joyce O'Shaughnessy, Aditya Bardia
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2947876005